258 related articles for article (PubMed ID: 17269979)
1. Vesicular pemphigoid with circulating autoantibodies against 230-kDa and 180-kDa proteins, and additional autoantibodies against 97-kDa and 45-kDa proteins.
Lai FJ; Sheu HM; Lee JY; Cheng CL; Chen W
Int J Dermatol; 2007 Feb; 46(2):206-9. PubMed ID: 17269979
[TBL] [Abstract][Full Text] [Related]
2. Lichen planus pemphigoides with circulating autoantibodies against 200 and 180 kDa epidermal antigens.
Yoon KH; Kim SC; Kang DS; Lee IJ
Eur J Dermatol; 2000; 10(3):212-4. PubMed ID: 10725820
[TBL] [Abstract][Full Text] [Related]
3. Antibody to bullous pemphigoid antigen 1 binds to the antigen at perilesional but not uninvolved skin, in localized bullous pemphigoid.
Seishima M; Izumi T; Kitajima Y
Eur J Dermatol; 1999; 9(1):39-42. PubMed ID: 9920986
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies to bullous pemphigoid and epidermolysis bullosa acquisita antigens in an infant.
Kawachi Y; Ikegami M; Hashimoto T; Matsumura K; Tanaka T; Otsuka F
Br J Dermatol; 1996 Sep; 135(3):443-7. PubMed ID: 8949441
[TBL] [Abstract][Full Text] [Related]
5. A vesicular variant of bullous pemphigoid with autoantibodies against unidentified 205- and 150-kDa proteins at the basement membrane zone.
Satoh S; Seishima M; Izumi T; Ito A; Kamiya H; Kitajima Y
Br J Dermatol; 1997 Nov; 137(5):768-73. PubMed ID: 9415239
[TBL] [Abstract][Full Text] [Related]
6. Canine bullous pemphigoid (BP): identification of the 180-kd canine BP antigen by circulating autoantibodies.
Iwasaki T; Olivry T; Lapiere JC; Chan LS; Peavey C; Liu YY; Jones JC; Ihrke PJ; Woodley DT
Vet Pathol; 1995 Jul; 32(4):387-93. PubMed ID: 7483213
[TBL] [Abstract][Full Text] [Related]
7. Concurrence of autoantibodies to bullous pemphigoid antigens and desmoglein 3: analysis of pathogenic and nonpathogenic antibodies.
Ono S; Tanioka M; Tanizaki H; Fujisawa A; Koga H; Hashimoto T; Kamiya K; Aoyama Y; Iwatsuki K; Miyachi Y
Br J Dermatol; 2013 Jun; 168(6):1357-60. PubMed ID: 23738642
[No Abstract] [Full Text] [Related]
8. [Bullous pemphigoid: diagnosis and therapy].
Kneisel A; Hertl M
Wien Med Wochenschr; 2014 Sep; 164(17-18):363-71. PubMed ID: 25077677
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid.
Ishiura N; Fujimoto M; Watanabe R; Nakashima H; Kuwano Y; Yazawa N; Echigo T; Okochi H; Tamaki K
J Dermatol Sci; 2008 Feb; 49(2):153-61. PubMed ID: 17920818
[TBL] [Abstract][Full Text] [Related]
10. Bullous pemphigoid associated with Shy-Drager syndrome.
Okazaki A; Iida T; Muramatsu T; Shirai T; Murata K; Takayanagi T
J Dermatol; 1998 Jul; 25(7):465-8. PubMed ID: 9714981
[TBL] [Abstract][Full Text] [Related]
11. A spontaneously arising porcine model of bullous pemphigoid.
Olivry T; Mirsky ML; Singleton W; Dunston SM; Borrillo AK; Xu L; Traczyk T; Rosolia DL; Chan LS
Arch Dermatol Res; 2000 Jan; 292(1):37-45. PubMed ID: 10664014
[TBL] [Abstract][Full Text] [Related]
12. IgE antibodies in sera from patients with bullous pemphigoid are autoantibodies preferentially directed against the 230-kDa epidermal antigen (BP230).
Ghohestani RF; Cozzani E; Delaporte E; Nicolas JF; Parodi A; Claudy A
J Clin Immunol; 1998 May; 18(3):202-9. PubMed ID: 9624579
[TBL] [Abstract][Full Text] [Related]
13. Immunofluorescence-negative bullous pemphigoid sera contain antibodies mostly directed against the 180 kDa bullous pemphigoid antigen (BPAg2).
Ghohestani RF; Claudy A
Br J Dermatol; 1997 Aug; 137(2):306-7. PubMed ID: 9292090
[No Abstract] [Full Text] [Related]
14. Bullous pemphigoid: from the clinic to the bench.
Di Zenzo G; Della Torre R; Zambruno G; Borradori L
Clin Dermatol; 2012; 30(1):3-16. PubMed ID: 22137222
[TBL] [Abstract][Full Text] [Related]
15. Serological studies in bullous pemphigoid: a literature review of antibody titers at presentation and in clinical remission.
Leuci S; Gürcan HM; Ahmed AR
Acta Derm Venereol; 2010 Mar; 90(2):115-21. PubMed ID: 20169293
[TBL] [Abstract][Full Text] [Related]
16. Childhood bullous pemphigoid: report of a case with characterization of the targeted antigens.
Trüeb RM; Didierjean L; Fellas A; Elias A; Borradori L
J Am Acad Dermatol; 1999 Feb; 40(2 Pt 2):338-44. PubMed ID: 10025864
[TBL] [Abstract][Full Text] [Related]
17. Case of pemphigoid vegetans positive with both BP180 and BP230 in enzyme-linked immunosorbent assays.
Nagamoto E; Fujisawa A; Jinnin M; Koga H; Ishii N; Hashimoto T; Yoshino Y
J Dermatol; 2014 Jul; 41(7):667-8. PubMed ID: 24985550
[No Abstract] [Full Text] [Related]
18. Autoantibodies from patients with localized and generalized bullous pemphigoid immunoprecipitate the same 230-kd keratinocyte antigen.
Domloge-Hultsch N; Utecht L; James W; Yancey KB
Arch Dermatol; 1990 Oct; 126(10):1337-41. PubMed ID: 2221940
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of histological criteria for bullous pemphigoid. Correlation with antigens recognized by immunoblotting of anti-epidermal autoantibodies].
Courville P; Kupfer I; Gilbert D; Thomine E; Metayer J; Joly P
Ann Pathol; 2000 Dec; 20(6):564-9. PubMed ID: 11148352
[TBL] [Abstract][Full Text] [Related]
20. IgG autoantibodies from a lichen planus pemphigoides patient recognize the NC16A domain of the bullous pemphigoid antigen 180.
Skaria M; Salomon D; Jaunin F; Friedli A; Saurat JH; Borradori L
Dermatology; 1999; 199(3):253-5. PubMed ID: 10592407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
